Marjun Á Fríðirksmørk Berbisá1,2, Kári Rubek Nielsen3, Anna Cäcilia Ingham4, Jóngerð Midjord3, Turið Hammer5, Poula Patursson3, Nicolina M O Vest2, Noomi O Gregersen6, Johan Burisch7, Amanda Vang2,8. 1. Department of Science and Technology, Aarhus University, Aarhus, Denmark. 2. Department of Health Sciences, University of the Faroe Islands, Tórshavn, Faroe Islands. 3. Department of Medicine, National Hospital of the Faroe Islands, Tórshavn, Faroe Islands. 4. Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark. 5. Department of Occupational Medicine and Public Health, The Faroese Hospital System, Tórshavn, Faroe Islands. 6. FarGen Project, Genetic Biobank of the Faroe Islands, Tórshavn, Faroe Islands. 7. Gastrounit, Medical Division, Hvidovre University Hospital, Hvidovre, Denmark. 8. Department of Biotechnology, Fiskaaling, Tórshavn, Faroe Islands.
Abstract
BACKGROUND: The Faroe Islands has the world's highest incidence of inflammatory bowel disease (IBD). Epidemiological studies have characterized this unique cohort and a decreased risk of developing IBD with emigration. Therefore, this well-characterized Faroese IBD cohort gives the opportunity to better understand this complex disease. This study represents the first investigation of the gut microbiota for the cohort. METHODS: This cross-sectional study consisted of 41 patients with established ulcerative colitis and 144 age- and sex-matched healthy controls recruited through the Faroe Genome project. Participants donated a 1-time fecal sample and completed questionnaires on food frequency, background health, and lifestyle. 16S rRNA amplicon sequencing of the V3-V4 region was performed followed by bioinformatic analysis of taxonomy and diversity metrics. RESULTS: The overall bacterial composition in both groups was dominated by Firmicutes and Bacteroidetes. No significant differences were found based on metrics of alpha or beta diversity. However, discriminatory analysis identified differential abundance of several indicator taxa in healthy controls and ulcerative colitis participants, whereas Akkermansia was completely absent from 27% of all study participants. Food frequency questionnaires revealed similar dietary patterns between the 2 groups. CONCLUSION: The similarity in bacterial community composition and absence of the beneficial Akkermansia genus in both groups raise further questions concerning the underlying susceptibility toward inflammatory disorders within this high-risk population. Results vary widely by study design and geographic location, which speaks to the need for regionally tuned reference groups and disease-based studies on the Faroe Islands.
BACKGROUND: The Faroe Islands has the world's highest incidence of inflammatory bowel disease (IBD). Epidemiological studies have characterized this unique cohort and a decreased risk of developing IBD with emigration. Therefore, this well-characterized Faroese IBD cohort gives the opportunity to better understand this complex disease. This study represents the first investigation of the gut microbiota for the cohort. METHODS: This cross-sectional study consisted of 41 patients with established ulcerative colitis and 144 age- and sex-matched healthy controls recruited through the Faroe Genome project. Participants donated a 1-time fecal sample and completed questionnaires on food frequency, background health, and lifestyle. 16S rRNA amplicon sequencing of the V3-V4 region was performed followed by bioinformatic analysis of taxonomy and diversity metrics. RESULTS: The overall bacterial composition in both groups was dominated by Firmicutes and Bacteroidetes. No significant differences were found based on metrics of alpha or beta diversity. However, discriminatory analysis identified differential abundance of several indicator taxa in healthy controls and ulcerative colitis participants, whereas Akkermansia was completely absent from 27% of all study participants. Food frequency questionnaires revealed similar dietary patterns between the 2 groups. CONCLUSION: The similarity in bacterial community composition and absence of the beneficial Akkermansia genus in both groups raise further questions concerning the underlying susceptibility toward inflammatory disorders within this high-risk population. Results vary widely by study design and geographic location, which speaks to the need for regionally tuned reference groups and disease-based studies on the Faroe Islands.
Authors: R Santer; M Kinner; U Steuerwald; S Kjaergaard; F Skovby; H Simonsen; W L Shaiu; Y T Chen; R Schneppenheim; J Schaub Journal: Eur J Hum Genet Date: 2001-05 Impact factor: 4.246
Authors: Mélanie Deschasaux; Kristien E Bouter; Andrei Prodan; Evgeni Levin; Albert K Groen; Hilde Herrema; Valentina Tremaroli; Guido J Bakker; Ilias Attaye; Sara-Joan Pinto-Sietsma; Daniel H van Raalte; Marieke B Snijder; Mary Nicolaou; Ron Peters; Aeilko H Zwinderman; Fredrik Bäckhed; Max Nieuwdorp Journal: Nat Med Date: 2018-08-27 Impact factor: 53.440
Authors: Adam G Clooney; Julia Eckenberger; Emilio Laserna-Mendieta; Kathryn A Sexton; Matthew T Bernstein; Kathy Vagianos; Michael Sargent; Feargal J Ryan; Carthage Moran; Donal Sheehan; Roy D Sleator; Laura E Targownik; Charles N Bernstein; Fergus Shanahan; Marcus J Claesson Journal: Gut Date: 2020-06-14 Impact factor: 23.059